– Record Quarterly Revenue of $148.3 million – – Quarterly Operating Profit of $17.4 million – – Quarterly Net Income of $8.1 million – – Quarterly Adjusted EBITDA1 of $30.3 million – – Record Backlog and Awarded Orders of $747.6 million – – Provides First Quarter and Full Year 2026 Outlook – PORTLAND, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions and components, inclu ...

Revenues at the upper end of guidance and pivot to EBITDA profitability - expectations for 2026 unchanged and guidance reiterated Revenues expected to increase c.30% as OXB continues to execute its strategy, FY 2025 revenues expected to be £166-169 million (£168 - 171 million CC1), at the upper end of guidance of £160-170 million (CC) (FY 2024: £128.8 million)FY 2025 Operating EBITDA2 profitability expected to be mid-to-high single-digit £ million (CC) including a larger than expected non-recurring gain fro ...

2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or $0.16 per diluted share, in 20242025 Adjusted EBITDA(1) increased 8.2% to $594 million, compared to 2024, or 7.8% on a constant currency basis2025 Adjusted EPS(1) of $0.86, an increase of $0.16 per diluted share, compared to 2024Full-year 2026 outlook: net revenues growth of 5.0% to 6.5% and Ad ...

RICHMOND, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will participate in the following upcoming investor conferences: Barclays 28th Annual Global Healthcare Conference – Miami, FLJoe Ciaffoni, Chief Executive Officer, will host 1x1 / group meetings on Tuesday, March 10th. Joe Ciaffoni will also participate in a fireside chat on Tuesday, March 10th at 2:00 p.m. U.S. EST. Interested investors should contact their Barclays representative to sche ...

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 24 February 2026 – Theon International Plc (THEON) (ISIN: CY0200751713) entered on 21st January 2026, into a Liquidity Contract with Kepler Cheuvreux (the "Liquidity Agreement"). Under the Liquidity Agreement, an initial amount of €1 million and 33,000 Shares were made available to Kepler Cheuvreux, to enhance the liquidity of the Shares in THEON on the regulated market of Euronext Amsterdam. On February 18, 2026, Parties have agreed that THEON will m ...

MONTRÉAL, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce that it has entered into a definitive agreement to acquire Terraco Gold Corp. (“Terraco”), a wholly-owned subsidiary of Sailfish Royalty Corp., which indirectly owns net smelter return (“NSR”) royalty assets (the “NSR Royalties”), largely consisting of royalties that cover Solidus Resources LLC’s (“Solidus”) Spring Valley Gold Project (“Spring Valley” or the “Project”) loca ...

Core Viewpoint - BioNTech SE will announce its financial results for Q4 and full year 2025 on March 10, 2026, and will host a conference call and webcast for stakeholders to discuss these results and provide a corporate update [1]. Company Overview - BioNTech is a global next-generation immunotherapy company focused on developing novel therapies for cancer and other serious diseases, utilizing a variety of computational discovery and therapeutic modalities [4]. - The company has a diversified portfolio of oncology product candidates, including mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies [4]. - BioNTech is also researching and developing multiple mRNA vaccine candidates for various infectious diseases, leveraging its expertise in mRNA development and in-house manufacturing capabilities [4]. - The company has established partnerships with several global and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Pfizer, and Genentech, among others [4].

WILMINGTON, Del., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (NASDAQ:GBLI) (“GBLI”) announced today that it will release its 2025 earnings results before market open on Tuesday, March 10, 2026. GBLI will hold an earnings call to discuss 2025 results on Tuesday, March 10, 2026 at 11:00 a.m. Eastern. The earnings call will be webcast on GBLI’s website at www.gbli.com. To participate via telephone, please register in advance using this link, https://register-conf.media-server.com/register/BI ...

THE WOODLANDS, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its fourth quarter and full year 2025 earnings release and conference call. Ring plans to issue its fourth quarter and full year 2025 earnings release after the close of trading on Wednesday, March 4, 2026. The Company has scheduled a conference call on Thursday, March 5, 2026 at 11:00 a.m. ET (10:00 a.m. CT) to discuss its fourth quarter and full year 2025 o ...

Core Insights - Bimergen Energy Corporation has received formal approval for its Redbird project, a 100 MW / 400 MWh battery energy storage system in Texas, under its Joint Development Agreement [1][2] - The project will utilize Eos Energy Enterprises' Z3™ zinc-based battery technology, enhancing its execution towards commercial operations in the ERCOT market [1][2] Company Overview - Bimergen Energy Corporation is a U.S.-based independent power producer focused on utility-scale battery energy storage systems, managing the entire project lifecycle from development to operations [5] - The company aims to provide grid reliability, renewable integration, and flexible energy solutions through its battery energy storage systems [5] Project Details - The Redbird BESS is designed to offer dispatchable storage capacity, improving grid reliability and supporting renewable energy integration [3] - The project is crucial for maintaining system stability in Texas, which is experiencing rapid load growth due to economic expansion and population increases [3] Strategic Importance - The approval and technology selection signify a major advancement for Bimergen, reflecting its commitment to safe and reliable multi-hour storage solutions [4] - The project is expected to deliver long-term value and enhance grid resilience across ERCOT, addressing the growing demand for dependable energy storage [4]